Hydralazine Hydrochloride Tablet
Product Images NDC 33342-375

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 33342-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

152 (Hydralazine 10 mg 1000s)

Each tablet contains Hydralazine Hydrochloride, USP 10 mg. The recommended dosage should be checked in the package insert for complete prescribing information. The medication should be stored in a tightly sealed container away from light in a temperature range of 20°C to 25°C. The tablets are manufactured for Macleods Pharma USA, Inc. and are available in a pack containing 1000 tablets. Always keep this medication out of reach of children.*

FDA Label Image

111 (Hydralazine 10 mg 100s)

This is information for Hydralazine Hydrochloride tablets, USP, containing 10mg. The usual dosage and storage instructions are provided, along with details on the manufacturer, Macleods Pharma USA, Inc. The tablets should be kept in a tight, light-resistant container at 20° to 25°C with excursions permitted between 15° to 30°C. The NDC for this medication is 33342-374-11.*

FDA Label Image

138 (Hydralazine 10 mg 10x10s)

This is a medication label for Hydralazine Hydrochloride Tablets, USP in a 100 unit-dose package. It contains 10 mg of Hydralazine Hydrochloride per tablet. The tablets are manufactured by Macleods Pharmaceuticals Ltd in India and distributed by Macleods Pharma USA in New Jersey. The usual storage conditions are between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Please refer to the package insert for full prescribing information. Keep this and all medications out of reach of children.*

FDA Label Image

123 (Hydralazine 100 mg 1000s)

Each tablet contains 100 mg of Hydralazine Hydrochloride, USP. The medication should be stored in a tight, light-resistant container between 20° to 25°C (68° to 77°F) and should be protected from temperatures up to 30°C (86°F). This product is manufactured by Macleods Pharma USA, Inc. and packaged by Madelods Pharmaceuticals Ltd. in India. The combination of active ingredient and storage instructions ensure the potency and effectiveness of this medication.*

FDA Label Image

169 (Hydralazine 100 mg 100s)

Each tablet contains Hydralazine Hydrochloride, USP 100 mg. The usual dosage can be found in the package insert for full prescribing information. Hydralazine should be dispensed in a tightly sealed, light-resistant container. Store between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is essential to keep this medication out of reach of children. This product is manufactured by Macleods Pharma USA, Inc. for Macleods Pharmaceuticals Ltd.*

FDA Label Image

196 (Hydralazine 100 mg 10x10s)

This text is a label from a packaging of Hydralazine Hydrochloride Tablets, USP 100 mg. It contains information about the manufacturer, batch number, expiration date, and storage instructions. The tablets are manufactured by Macleods Pharmaceuticals Ltd in India and distributed by Macleods Pharma USA, Inc. The usual dosage and storage conditions are provided on the package, including temperature requirements for storage.*

FDA Label Image

147 (Hydralazine 25 mg 1000s)

This text is a label for Hydralazine Hydrochloride Tablets, USP with 1000 tablets containing 25mg of hydralazine hydrochloride. The label provides information on the usual dosage and storage requirements. The tablets are manufactured by Macleods Pharmaceuticals Ltd. in India for Macleods Pharma USA, Inc. located in Princeton, NJ.*

FDA Label Image

122 (Hydralazine 25 mg 100s)

This text appears to be information regarding a medication product containing Hydralazine Hydrochloride, USP 25 mg in tablet form. The usual dosage and storage instructions are provided along with details about the manufacturer. The tablets are stored in a temperature range of 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It is important to consult the package insert for full prescribing information before use.*

FDA Label Image

157 (Hydralazine 25 mg 10x10s)

This text provides information about Hydralazine Hydrochloride Tablets, USP by Raczops Pharma USA. The tablets come in a 10x10 unit-dose pack containing 100 tablets. Each tablet contains 25mg of Hydralazine Hydrochloride, USP. The tablets should be stored at 20° to 25°C and excursions are permitted between 15° to 30°C. The package insert should be reviewed for full prescribing information. The product is manufactured by Macleods Pharmaceuticals Ltd in India and distributed by Macleods Pharma USA, Inc.*

FDA Label Image

159 (Hydralazine 50 mg 1000s)

Each tablet contains Hydralazine Hydrochloride at a strength of 50 mg. The tablets are manufactured by Macleods Pharma USA, Inc. and come in a package of 1000 tablets. The usual dosage should be referred to the package insert for complete prescribing information. The medication should be stored in a tight, light-resistant container at a temperature between 15°C to 30°C (59°F to 86°F) and kept out of reach of children.*

FDA Label Image

169 (Hydralazine 50 mg 100s)

Description: This text is an excerpt of the medication label for Hydralazine Hydrochloride tablets USP containing 50 mg. It includes information on storage conditions, dosage, manufacturer details (Macleods Pharma USA, Inc.), and instructions to keep the medication out of reach of children. The tablets are to be dispensed in a tight, light-resistant container and stored between 20° to 25°C, with permitted excursions between 15° to 30°C. Additional details such as National Drug Code (NDC) and manufacturing locations in Princeton, NJ, and Baddi, Himachal Pradesh, INDIA are also provided.*

FDA Label Image

139 (Hydralazine 50 mg 10x10s)

This is a description of Hydralazine Hydrochloride Tablets, USP 50 mg in a package containing 140 tablets (10x 14 unit-dose). The tablets are manufactured by Macleods Pharmaceuticals Ltd. in India and distributed by Macleods Pharma USA. The recommended storage temperature for the tablets is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (50°F to 86°F). The packaging includes dosage instructions and a caution to keep the medication out of reach of children.*

FDA Label Image

136 (Hydralazine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.